Fractalkine and CX3CR1 are involved in the migration of intravenously grafted human bone marrow stromal cells toward ischemic brain lesion in rats

Brain Research

Volumn 1287, Issue , 2009, Pages 173-183

  Zhu, Jie ^a   Zhou, Zhujuan ^a   Liu, Yong ^a   Zheng, Jian ^a  

^a THIRD MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

Cerebral infarct; CX3CR1; Fractalkine; Human bone marrow stromal cells; Migration; RNA interference

Indexed keywords

CHEMOKINE RECEPTOR CX3CR1; FRACTALKINE; GREEN FLUORESCENT PROTEIN;

ADULT; ANIMAL CELL; ARTICLE; BONE MARROW CELL; BONE MARROW TRANSPLANTATION; BRAIN ISCHEMIA; CELL CULTURE; CELL MIGRATION; CONTROLLED STUDY; HUMAN; HUMAN CELL; MALE; MIDDLE CEREBRAL ARTERY OCCLUSION; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; REAL TIME POLYMERASE CHAIN REACTION; STROMA CELL; WESTERN BLOTTING;

ADOLESCENT; ADULT; ANIMALS; BONE MARROW CELLS; BONE MARROW TRANSPLANTATION; BRAIN ISCHEMIA; CELL MIGRATION INHIBITION; CELLS, CULTURED; CHEMOKINE CX3CL1; GENE KNOCKDOWN TECHNIQUES; HUMANS; INJECTIONS, INTRAVENOUS; MALE; MIDDLE AGED; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, CHEMOKINE; STROMAL CELLS; YOUNG ADULT;

LENTIVIRUS; RATTUS;

EID: 68049092911     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.brainres.2009.06.068     Document Type: Article

References (40)

1. Campbell D.J., Kim C.H., and Butcher E.C. Chemokines in the systemic organization of immunity. Immunol. Rev. 195 (2003) 58-71
2. Cartier L., Hartley O., Dubois Dauphin M., and Krause K.H. Chemokine receptors in the central nervous system: role in brain inflammation and neurodegenerative diseases. Brain Res. Brain Res. Rev. 48 1 (2005) 16-42
3. Chen J.R., Cheng G.Y., Sheu C.C., Tseng G.F., Wang T.J., and Huang Y.S. Transplanted bone marrow stromal cells migrate, differentiate and improve motor function in rats with experimentally induced cerebral stroke. J. Anat. 213 (2008) 249-258
4. Constantin G. Chemokine signaling and integrin activation in lymphocyte migration into the inflamed brain. J. Neuroimmunol. 198 (2008) 20-26
5. Fong A.M., Robinson L.A., Steeber D.A., Tedder T.F., Yoshie O., Imai T., and Patel D.D. Fractalkine and CX3CR1 mediate a novel mechanism of leukocyte capture, firm adhesion, and activation under physiologic flow. J. Exp. Med. 188 8 (1998) 1413-1419
6. Harrison J.K., Jiang Y., Chen S., Xia Y., Maciejewski D., McNamara R.K., Streit W.J., Salafranca M.N., Adhikari S., Thompson D.A., Botti P., Bacon K.B., and Feng L. Role for neuronally derived fractalkine in mediating interactions between neurons and CX3CR1-expressing microglia. Proc. Natl. Acad. Sci. U. S. A. 95 (1998) 10896-10901
7. Honczarenko M., Le Y., Swierkowski M., Ghiran I., Glodek A.M., and Silberstein L.E. Human bone marrow stromal cells express a distinct set of biologically functional chemokine receptors. Stem Cells 24 (2006) 1030-1041
8. Hughes P.M., Botham M.S., Frentzel S., Mir A., and Perry V.H. Expression of fractalkine (CX3CL1) and its receptor, CX3CR1, during acute and chronic inflammation in the rodent CNS. Glia 37 (2002) 314-327
9. Imai T., Hieshima K., Haskell C., Baba M., Nagira M., Nishimura M., Kakizaki M., Takagi S., Nomiyama H., Schall T.J., and Yoshie O. Identification and molecular characterization of fractalkine receptor CX3CR1, which mediates both leukocyte migration and adhesion. Cell 91 4 (1997) 521-530
10. Ji J.F., He B.P., Dheen S.T., and Tay S.S. Interactions of chemokines and chemokine receptors mediate the migration of mesenchymal stem cells to the impaired site in the brain after hypoglossal nerve injury. Stem Cells 22 (2004) 415-427
11. Lee R.H., Hsu S.C., Munoz J., Jung J.S., Lee N.R., Pochampally R., and Prockop D.J. A subset of human rapidly self-renewing marrow stromal cells preferentially engraft in mice. Blood 107 (2006) 2153-2161
12. Li M., and Ransohoff R.M. Multiple roles of chemokine CXCL12 in the central nervous system: a migration from immunology to neurobiology. Prog. Neurobiol. 84 (2008) 116-131
13. Liu W., Jiang X., Fu X., Cui S., Du M., Cai Y., and Xu R. Bone marrow stromal cells can be delivered to the site of traumatic brain injury via intrathecal transplantation in rabbits. Neurosci. Lett. 434 (2008) 160-164
14. Longa E.Z., Weinstein P.R., Carlson S., and Cummins R. Reversible middle cerebral artery occlusion without craniectomy in rats. Stroke 20 (1989) 84-91
15. Lu J., Moochhala S., Moore X.L., Ng K.C., Tan M.H., Lee L.K., He B., Wong M.C., and Ling E.A. Adult bone marrow cells differentiate into neural phenotypes and improve functional recovery in rats following traumatic brain injury. Neurosci. Lett. 398 (2006) 12-17
16. Mines M., Ding Y., and Fan G.H. The many roles of chemokine receptors in neurodegenerative disorders: emerging new therapeutical strategies. Curr. Med. Chem. 14 (2007) 2456-2470
17. Mizuno T., Kawanokuchi J., Numata K., and Suzumura A. Production and neuroprotective functions of fractalkine in the central nervous system. Brain Res. 979 (2003) 65-70
18. Nagasawa H., and Kogure K. Correlation between cerebral blood flow and histologic changes in a new rat model of middle cerebral artery occlusion. Stroke 20 (1989) 1037-1043
19. Pan Y., Lloyd C., Zhou H., Dolich S., Deeds J., Gonzalo J.A., Vath J., Gosselin M., Ma J., Dussault B., Woolf E., Alperin G., Culpepper J., Gutierrez Ramos J.C., and Gearing D. Neurotactin, a membrane-anchored chemokine upregulated in brain inflammation. Nature 387 (1997) 611-617
20. Parr A.M., Tator C.H., and Keating A. Bone marrow-derived mesenchymal stromal cells for the repair of central nervous system injury. Bone Marrow Transplant. 40 (2007) 609-619
21. Prockop D.J. Marrow stromal cells as stem cells for nonhematopoietic tissues. Science 276 (1997) 71-74
22. Prockop D.J. Marrow stromal cells as stem cells for continual renewal of nonhematopoietic tissues and as potential vectors for gene therapy. J. Cell. Biochem., Suppl. 30-31 (1998) 284-285
23. Prockop D.J., Gregory C.A., and Spees J.L. One strategy for cell and gene therapy: harnessing the power of adult stem cells to repair tissues. Proc. Natl. Acad. Sci. U. S. A. 100 Suppl. 1 (2003) 11917-11923
24. Re D.B., and Przedborski S. Fractalkine: moving from chemotaxis to neuroprotection. Nat. Neurosci. 9 (2006) 859-861
25. Seyfried D., Ding J., Han Y., Li Y., Chen J., and Chopp M. Effects of intravenous administration of human bone marrow stromal cells after intracerebral hemorrhage in rats. J. Neurosurg. 104 (2006) 313-318
26. Shen L.H., Li Y., Chen J., Zhang J., Vanguri P., Borneman J., and Chopp M. Intracarotid transplantation of bone marrow stromal cells increases axon-myelin remodeling after stroke. Neuroscience 137 (2006) 393-399
27. Shichinohe H., Kuroda S., Lee J.B., Nishimura G., Yano S., Seki T., Ikeda J., Tamura M., and Iwasaki Y. In vivo tracking of bone marrow stromal cells transplanted into mice cerebral infarct by fluorescence optical imaging. Brain Res. Brain Res. Protoc. 13 (2004) 166-175
28. Shichinohe H., Kuroda S., Yano S., Hida K., and Iwasaki Y. Role of SDF-1/CXCR4 system in survival and migration of bone marrow stromal cells after transplantation into mice cerebral infarct. Brain Res. 1183 (2007) 138-147
29. Shyu W.C., Chen C.P., Lin S.Z., Lee Y.J., and Li H. Efficient tracking of non-iron-labeled mesenchymal stem cells with serial MRI in chronic stroke rats. Stroke 38 (2007) 367-374
30. Sordi V., Malosio M.L., Marchesi F., Mercalli A., Melzi R., Giordano T., Belmonte N., Ferrari G., Leone B.E., Bertuzzi F., Zerbini G., Allavena P., Bonifacio E., and Piemonti L. Bone marrow mesenchymal stem cells express a restricted set of functionally active chemokine receptors capable of promoting migration to pancreatic islets. Blood 106 (2005) 419-427
31. Soriano S.G., Amaravadi L.S., Wang Y.F., Zhou H., Yu G.X., Tonra J.R., Fairchild Huntress V., Fang Q., Dunmore J.H., Huszar D., and Pan Y. Mice deficient in fractalkine are less susceptible to cerebral ischemia-reperfusion injury. J. Neuroimmunol. 125 (2002) 59-65
32. Sunnemark D., Eltayeb S., Nilsson M., Wallstrom E., Lassmann H., Olsson T., Berg A.L., and Ericsson-Dahlstrand A. CX3CL1 (fractalkine) and CX3CR1 expression in myelin oligodendrocyte glycoprotein-induced experimental autoimmune encephalomyelitis: kinetics and cellular origin. J. Neuroinflammation 2 (2005) 17
33. Tarozzo G., Campanella M., Ghiani M., Bulfone A., and Beltramo M. Expression of fractalkine and its receptor, CX3CR1, in response to ischaemia-reperfusion brain injury in the rat. Eur. J. Neurosci. 15 (2002) 1663-1668
34. Wang L., Li Y., Chen X., Chen J., Gautam S.C., Xu Y., and Chopp M. MCP-1, MIP-1, IL-8 and ischemic cerebral tissue enhance human bone marrow stromal cell migration in interface culture. Hematology 7 (2002) 113-117
35. Wang L., Li Y., Chen J., Gautam S.C., Zhang Z., Lu M., and Chopp M. Ischemic cerebral tissue and MCP-1 enhance rat bone marrow stromal cell migration in interface culture. Exp. Hematol. 30 (2002) 831-836
36. Wang Y., Deng Y., and Zhou G.Q. SDF-1alpha/CXCR4-mediated migration of systemically transplanted bone marrow stromal cells towards ischemic brain lesion in a rat model. Brain Res. 1195 (2008) 104-112
37. Wu J., Sun Z., Sun H.S., Wu J., Weisel R.D., Keating A., Li Z.H., Feng Z.P., and Li R.K. Intravenously administered bone marrow cells migrate to damaged brain tissue and improve neural function in ischemic rats. Cell Transplant 16 (2008) 993-1005
38. Yano S., Kuroda S., Lee J.B., Shichinohe H., Seki T., Ikeda J., Nishimura G., Hida K., Tamura M., and Iwasaki Y. In vivo fluorescence tracking of bone marrow stromal cells transplanted into a pneumatic injury model of rat spinal cord. J. Neurotrauma. 22 (2005) 907-918
39. Yano S., Kuroda S., Shichinohe H., Hida K., and Iwasaki Y. Do bone marrow stromal cells proliferate after transplantation into mice cerebral infarct?-a double labeling study. Brain Res. 1065 (2005) 60-67
40. Zhang J., Li Y., Lu M., Cui Y., Chen J., Noffsinger L., Elias S.B., and Chopp M. Bone marrow stromal cells reduce axonal loss in experimental autoimmune encephalomyelitis mice. J. Neurosci. Res. 84 (2006) 587-595